3T Biosciences Email Format
Biotechnology ResearchCalifornia, United States11-50 Employees
3T Biosciences is a biotechnology research company focused on immunotherapy, headquartered at 681 Gateway Boulevard, South San Francisco, California 94080. The company develops next-generation therapies designed to treat solid tumors and other immune-mediated diseases by leveraging the immune system to recognize and destroy cancer cells. It employs 11 to 50 people. In January 2026, Behzad Kharabi, M.D., was appointed chief medical officer, and the company has engaged in partnerships with Boehringer Ingelheim to develop next-generation cancer immunotherapies. Reported revenue is in the range of $10 million to $25 million, and total funding is around $40 million.